A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
Authors
Keywords
-
Journal
EUROPEAN UROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-16
DOI
10.1016/j.eururo.2021.12.013
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
- (2021) Jonas F Ludvigsson et al. Clinical Epidemiology
- Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide
- (2021) Fei Li et al. Nature Communications
- 5α-Reductase Inhibitors are Associated with Reduced Risk of SARS-COV-2 Infection: A Matched-Pair, Registry-Based Analysis.
- (2021) Madison Lyon et al. JOURNAL OF UROLOGY
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- (2021) D. A. Leach et al. Nature Communications
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- (2021) John McCoy et al. Frontiers in Medicine
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)
- (2020) Jasper Fuk-Woo Chan et al. CLINICAL INFECTIOUS DISEASES
- Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”
- (2020) Carlos Gustavo Wambier et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Viral and host factors related to the clinical outcome of COVID-19
- (2020) Xiaonan Zhang et al. NATURE
- Does androgen deprivation therapy protect against severe complications from COVID-19?
- (2020) V.G. Patel et al. ANNALS OF ONCOLOGY
- Androgen deprivation and SARS-CoV-2 in men with prostate cancer
- (2020) M. Koskinen et al. ANNALS OF ONCOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
- (2020) Hannah Peckham et al. Nature Communications
- Pharmacokinetic Drug Interaction Studies with Enzalutamide
- (2015) Jacqueline A. Gibbons et al. CLINICAL PHARMACOKINETICS
- Androgen receptor and androgen-dependent gene expression in lung
- (2009) Laura Mikkonen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now